Leukemic stem cells: A review

Cancer Investigation

Volumn 31, Issue 4, 2013, Pages 215-220

  O'Brien, J A ^a   Rizzieri, D A ^b  

^a Department of Medicine   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Leukemia; Leukemic stem cells; Stem cell therapy

Indexed keywords

CD123 ANTIGEN; MONOCLONAL ANTIBODY; PLEIOTROPHIN; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN;

ANIMAL MODEL; CANCER PATIENT; CANCER STEM CELL; DISEASE COURSE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; LEUKEMIC STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; NEOPLASTIC STEM CELLS;

EID: 84876936145     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.700986     Document Type: Review

References (34)

1. ClarkeMF, BeckerMW. Stem cells: the real culprits in cancer? Sci Am 2006;295:52-59.
2. Dick JE. Acute myeloid leukemia stem cells. Ann NY Acad Sci 2005;1044:1-5. (Pubitemid 40967588)
3. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737. (Pubitemid 27298715)
4. Jordan CT. Unique molecular and cellular features of acute myelogenous leukemia stem cells. 26, and Off J Leukemia Soc Am, Leukemia Research Fund, U.K. 2002;16:559-562. (Pubitemid 34449733)
5. Huntly BJ, Gilliland DG. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer 2005;5:311-321. (Pubitemid 40488636)
6. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003;3:895-902. (Pubitemid 37500174)
7. Guzman ML, Rossi RM, Karnischky L, Li X, PetersonDR,Howard DS, Jordan CT. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005;105:4163-4169. (Pubitemid 40720758)
8. Wang JC. Evaluating therapeutic efficacy against cancer stem cells: new challenges posed by a new paradigm. Cell Stem Cell 2007;1:497-501. (Pubitemid 350056411)
9. Reya T,Morrison SJ, Clarke MF,Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111. (Pubitemid 33041634)
10. Cleary MA. Counterpoint: in some AMLs, stem cells are more mature and present at high frequency. ASH Annual Meeting Abstracts 2009;114:SCI-35.
11. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A, Sawyers CL, Weissman IL. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. New Engl J Med 2004;351:657-667. (Pubitemid 39063268)
12. Cozzio A, Passegue E, Ayton PM, KarsunkyH, ClearyML,Weissman IL. Similar MLL-associated leukemias arising from selfrenewing stem cells and short-lived myeloid progenitors. Gene Dev 2003;17:3029-3035. (Pubitemid 38040767)
13. Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N, Rowan R, Amaral S, Curley D, Williams IR, Akashi K, Gilliland DG. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004;6:587-596. (Pubitemid 40017702)
14. Somervaille TC, Cleary ML. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 2006;10:257-268. (Pubitemid 44512188)
15. Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Jordan CT. Nuclear factor-kappab is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001;98:2301-2307.
16. Guzman ML, Swiderski CF, Howard DS, Grimes BA, Rossi RM, Szilvassy SJ, Jordan CT. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci USA 2002;99:16220-16225. (Pubitemid 35462776)
17. Laurent G, Jaffrezou JP. Signaling pathways activated by daunorubicin. Blood 2001;98:913-924.
18. Takimoto CH, Calvo E. Principles of oncologic pharmacotherapy. In Cancer Management: A Multidisciplinary Approach Medical, Surgical & Radiation Oncology, 11th edition, R Pazdur, LD Wagman, KA Camphausen, and WJ Hoskins (eds.), UBM Medica. 2008.
19. Shang S, Lin ZN, Yang CF, Shi X, Ong CN, Shen HM. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells. Carcinogenesis 2004;25:2191-2199. (Pubitemid 39534857)
20. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, Munchhof M, VanArsdale T, Beachy PA, Reya T. Hedgehog signalling is essential formaintenance of cancer stem cells inmyeloid leukaemia.Nature 2009;458:776-779.
21. Shah NP, Tran C, Lee FY, Chen P,NorrisD, Sawyers CL.Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 2004;305:399-401. (Pubitemid 38938156)
22. Chen JK, Taipale J, Cooper MK, Beachy PA. Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened. Gene Dev 2002;16:2743-2748. (Pubitemid 35253140)
23. Himburg HA, Muramoto GG, Daher P, Meadows SK, Russell JL, Doan P, Chi JT, Salter AB, Lento WE, Reya T, Chao NJ, Chute JP. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nat Med 2010;16:475-482.
24. Jin L, Hope KJ, ZhaiQ, Smadja-Joffe F, Dick JE. Targeting of cd44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006;12:1167-1174. (Pubitemid 44527352)
25. Carter P. Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001;1:118-129. (Pubitemid 33741887)
26. Bendall LJ, Bradstock KF, Gottlieb DJ. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells. Leukemia: Off J Leukemia Soc Am, Leukemia Research Fund, U.K. 2000;14:1239-1246. (Pubitemid 30445031)
27. Gadhoum Z, Leibovitch MP, Qi J, Dumenil D, Durand L, Leibovitch S, Smadja-Joffe F. CD44: a new means to inhibit acute myeloid leukemia cell proliferation via P27KIP1. Blood 2004;103:1059-1068. (Pubitemid 38129572)
28. CharradRS,GadhoumZ, Qi J, Glachant A, AlloucheM, JasminC, Chomienne C, Smadja-Joffe F. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 2002;99:290-299.
29. Jin L, Lee EM, RamshawHS, Busfield SJ, Peoppl AG,Wilkinson L, Guthridge MA,Thomas D, Barry EF, Boyd A, GearingDP, Vairo G, Lopez AF, Dick JE, Lock RB. Monoclonal antibody-mediated targeting of CD123, Il-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell 2009;5:31-42.
30. Bagley CJ, Woodcock JM, Stomski FC, Lopez AF. The structural and functional basis of cytokine receptor activation: lessons from the common beta subunit of the granulocyte-macrophage colonystimulating factor, interleukin-3 (Il-3), and Il-5 receptors. Blood 1997;89:1471-1482. (Pubitemid 27097437)
31. Frankel A, Liu JS, Rizzieri D, Hogge D. Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia. Leukemia Lymphoma 2008;49:543-553. (Pubitemid 351298340)
32. Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, Luger SM, Phillips GL.The interleukin-3 receptor alpha chain is a unique marker for human acutemyelogenous leukemia stem cells. Leukemia: Off J Leukemia Soc Am, Leukemia Research Fund, U.K. 2000;14:1777-1784.
33. Lamb J. The connectivity map: a new tool for biomedical research. Nat Rev Cancer 2007;7:54-60. (Pubitemid 46020847)
34. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR.Theconnectivity map: using geneexpression signatures to connect small molecules, genes, and disease. Science 2006;313:1929-1935. (Pubitemid 44497995)